Acute Trypanosoma cruzi infection is associated with anemia, thrombocytopenia, leukopenia, and bone marrow hypoplasia: Reversal by nifurtimox treatment

Microbes and Infection

Volumn 2, Issue 4, 2000, Pages 347-352

  Marcondes, Maria C G ^a   Borelli, Primavera ^b   Yoshida, Nobuko ^c   Russo, Momtchilo ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b Faculdade Cie Farmaceuticas   (Brazil)

^c FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Anemia; Bone marrow suppression; Nifurtimo; Thrombocytopenia; Trypanosoma cruzi

Indexed keywords

NIFURTIMOX;

ANEMIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE MARROW HYPOPLASIA; COLONY FORMING UNIT; CONTROLLED STUDY; FEMALE; LEUKOPENIA; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; THROMBOCYTOPENIA; TRYPANOSOMA CRUZI; TRYPANOSOMIASIS;

ANIMALIA; PROTOZOA; TRYPANOSOMA; TRYPANOSOMA CRUZI;

EID: 0034055691     PISSN: 12864579     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1286-4579(00)00333-6     Document Type: Article

References (28)

1. Chagas C. Nova tripanosomiaze humana. Mem. Inst. Oswaldo Cruz. 1:1909;3-62.
2. Cardoso J.E., Brener Z. Hematological changes in mice experimentally infected with Trypanosoma cruzi. Mem. Inst. Oswaldo Cruz. 75:1980;97-104.
3. Ikede B.O., Lule M., Terry R.J. Anemia in trypanosomiasis: mechanisms of erythrocyte destruction in mice infected with Trypanosoma congolense or T. brucei. Acta Trop. 34:1977;53-60.
4. Russo M., Starobinas N., Ribeiro Dos Santos R., Minoprio P., Eisen H., Hontebeyrie-Joskowicz M. Susceptible mice present higher macrophage activation than resistant mice during infections with myotropic strains of Trypanosoma cruzi. Parasite Immunol. 11:1989;385-395.
5. Andrade S.G., Rassi A., Magalhaes J.B., Feriolli-Filho F., Luquetti A.O. Specific chemoterapy of Chagas disease: a comparison between the response in patients and experimental animals inoculated with the same strain. Trans. R. Soc. Trop. Med. Hyg. 86:1992;624-626.
6. Brown B.A. Lea, Febiger. Hematology, Principles and Practice, Fourth Edition, Philadelphia. 1984.
7. Van Kampen E.J., Zijstra W.G. Standardization of hemoglobinometry. II. The hemoglobin cyanide method. Clin. Chem. Acta. 6:1961;538-543.
8. Strumia M.M., Sample A.B., Hart E.D. An improved microhematocrit method. Am. J. Clin. Pathol. 24:1954;1016-1022.
9. Curry J.L., Trentin J.J. Hemopoietic spleen colony studies. I. Growth and differentiation. Dev. Biol. 15:1967;395-413.
10. Thomsen A.R., Pisa P., Bro-Jorgensen K., Kiessling R. Mechanisms of lymphocytic choriomeningitis virus-induced hemopoietic dysfunction. J. Virol. 59:1986;428-433.
11. Rakusan T.A. Inhibition of colony formation by human cytomegovirus in vitro. J. Infect. Dis. 159:1989;127-130.
12. Kaloutsi V., Kohlmeyer V., Maschet H., Nafe R., Choritz H., Amor A., Georgii A. Comparison of bone marrow and hematological findings in patients with human immunodeficiency virus infection and those with myelodisplastic syndromes and infectious diseases. Am. J. Clin. Pathol. 101:1994;123-129.
13. Miller L.H., Good M.F., Milon G. Malaria pathogenesis. Science. 264:1994;1878-1883.
14. Watier H., Verwaerde C., Landau I., Werner E., Fontaine J., Capron A., Auriault C. T cell-dependent immunity and thrombocytopenia in rats infected with Plasmodium chabaudi. Infect. Immun. 60:1992;136-142.
15. Davis C.E., Robbins R.S., Weller R.D., Braude A.I. Thrombocytopenia in experimental trypanosomiasis. J. Clin. Invest. 53:1974;1359-1367.
16. Sindre H., Tjonnfjord G.E., Rollag H., Ronnenberg-Nielsen T., Veiby O.P., Beck S., Degré M., Hestdal K. Human cytomegalovirus suppression of and latency in early hematopoietic progenitor cells. Blood. 88:1996;4526-4533.
17. Schwartz G.N., Kessler S.W., Rothwell S.W., Burrel L.M., Reid T.J., Meltzer M.S., Wright D.G. Inhibitory effect of HIV-infected stromal cell layers on the production of myeloid progenitor cells in human long term bone marrow cultures. Exp. Hematol. 22:1994;1288-1296.
18. Binder D., Fehr J., Hengartner H., Zinkernagel R.M. Virus-induced transient bone marrow aplasia: major role of interferon-α/β during acute infection with the noncytopathic lymphocytic choriomeningitis virus. J. Exp. M. 185:1997;517-530.
19. + T cells in persistent infection with lymphocytic choriomeningitis virus. J. Exp. M. 187:1998;1903-1920.
20. Phillips R.E., Looareesuwan S., Warrel M., White N.J., Swasdichal C., Weatherall D.J. The importance of anemia in cerebral and uncomplicated falciparum malaria: role of complications, dyserythropoiesis and iron sequestration. Quarterly J. M. 58:1986;305-326.
21. Dormer P., Dietrich M., Kern P., Horstman R.D. Innefective erythropoiesis in acute human falciparum malaria. Blut. 46:1983;279-288.
22. Amole B.O., Clarkson A.B., Shear H.L. Pathogenesis of anemia in Trypanosoma brucei-infected mice. Infect. Immun. 36:1982;1060-1068.
23. Clayton C.E., Selkirk M.E., Corsini C.A., Ogilvie B.M., Askonas B.A. Murine trypanosomiasis: Cellular proliferation and functional depletion in the blood, peritoneum, and spleen related to changes in bone marrow stem cells. Infect. Immun. 28:1980;824-831.
24. Ben D., Chen M., Mueller M. Recombinant Tumor Necrosis Factor enhances the proliferative responsiveness of murine peripheral macrophages to Macrophage-Colony Stimulating Factor but inhibits their proliferative responsiveness to Granulocyte-Macrophage-Colony Stimulating Factor. Blood. 75:1990;1627-1632.
25. Cook D.N. The role of MIP-1α in inflammation and hematopoiesis. J. Leuk. Biol. 59:1996;61-74.
26. Moldawer L.L., Marano M.A., Wei H., Fong Y., Lilen M.L., Kuo G., Manogue K.R., Vlassara H., Cohen H., Cerami A. Cachectin/Tumor necrosis factor alpha alters red blood cell kinetics and induces anemia in vivo. FASEB J. 3:1989;1637-1643.
27. Starobinas N., Russo M., Minoprio P., Hontebeyrie-Joskowicz M. Is TNF-alpha involved in early susceptibility of Trypanosoma cruzi infected C3H/He mice? Res. Immunol. 142:1991;117-122.
28. Russo M., Starobinas N. Macrophage activation and resistance to Trypanosoma cruzi infection. Res. Immunol. 142:1991;144-146.